Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
OGN
Organon &
$9.59
Chart
15.33
14.62
14.58
21.77
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
OGN
Organon &
$9.59
Chart
15.33
14.62
14.58
21.77
OGN Latest Headlines
OGN INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP Announces Investigation into Organon & Co. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm. SAN DIEGO May 02 2025 (GLOBE NEWSWIRE) -- is investigating potential violations of United States federal securities laws involving Organon &. Co. (NYSE:) focused on whether Organon and certain of its top executives made false and/or misleading statements and/or failed to disclose mate
Today
Why The Low Payout Ratio Did Not Stop The Dividend Cut For Organon.
Today
Organon projects over $1B in Nexplanon revenue for 2025 amid continued expansion.
Thu May 1, 2025
Organon (OGN) Reports Q1 Earnings: What Key Metrics Have to Say. Although the revenue and EPS for Organon (OGN) give a sense of how its business performed in the quarter ended March 2025 it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Thu May 1, 2025
Organon drops after dividend cut.
Thu May 1, 2025
Organon cuts dividend by ~90%.
Thu May 1, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Latest Updates
Login to display Organon & (OGN) recommendation from the last 90 days from financial news and social media.
Hover over the category for more information
